These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38893710)

  • 21. Transperineal Multiparametric Magnetic Resonance Imaging-Ultrasound Fusion Targeted Prostate Biopsy Combined with Standard Template Improves Prostate Cancer Detection.
    Kim MM; Wu S; Lin SX; Crotty RK; Harisinghani M; Feldman AS; Wu CL; Dahl DM
    J Urol; 2022 Jan; 207(1):86-94. PubMed ID: 34428921
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of the optimal strategy in men with a single unilateral suspicious lesion on MRI undergoing transperineal MRI/ultrasound fusion prostate biopsy.
    Yusim I; Mazor E; Frumkin E; Jabareen M; Hefer B; Elsaraya N; Li S; Rouvinov K; Novack V; Mabjeesh NJ
    Prostate; 2023 Sep; 83(13):1255-1262. PubMed ID: 37263774
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of prostate cancer detection rates in patients undergoing MRI/TRUS fusion prostate biopsy with two different software-based systems.
    Hanske J; Risse Y; Roghmann F; Pucheril D; Berg S; Tully KH; von Landenberg N; Wald J; Noldus J; Brock M
    Prostate; 2022 Feb; 82(2):227-234. PubMed ID: 34734428
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Analysis of the relationship between PI-RADS scores and the pathological results of targeted biopsy based on MRI].
    Wang YM; Shang JW; Dong L; Liang LH; Zhao RZ; Liang C; Wang SQ; Xia W; Cheng G; Hua LX
    Zhonghua Zhong Liu Za Zhi; 2023 Nov; 45(11):942-947. PubMed ID: 37968079
    [No Abstract]   [Full Text] [Related]  

  • 25. Transperineal Versus Transrectal Targeted Biopsy With Use of Electromagnetically-tracked MR/US Fusion Guidance Platform for the Detection of Clinically Significant Prostate Cancer.
    Winoker JS; Wajswol E; Falagario U; Maritini A; Moshier E; Voutsinas N; Knauer CJ; Sfakianos JP; Lewis SC; Taouli BA; Rastinehad AR
    Urology; 2020 Dec; 146():278-286. PubMed ID: 32956688
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gleason Grade Group Concordance between Systematic Template Combining Magnetic Resonance Imaging Fusion Targeted Biopsy and Radical Prostatectomy Specimens: A Comparison of Transperineal and Transrectal Approaches.
    Wu S; Feldman AS; Kim MM; Lin SX; Cornejo KM; Harisinghani MG; Dahl DM; Wu CL
    Urology; 2023 May; 175():151-156. PubMed ID: 36828261
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of clinically significant prostate cancer by transperineal multiparametric magnetic resonance imaging-ultrasound fusion targeted prostate biopsy in smaller prostates.
    Dahl DM; Kim MM; Wu S; Lin SX; Crotty RK; Cornejo KM; Harisinghani MG; Feldman AS; Wu CL
    Urol Oncol; 2022 Oct; 40(10):451.e9-451.e14. PubMed ID: 36008257
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multicenter transperineal MRI-TRUS fusion guided outpatient clinic prostate biopsies under local anesthesia.
    Jacewicz M; Günzel K; Rud E; Lauritzen PM; Galtung KF; Hinz S; Magheli A; Baco E
    Urol Oncol; 2021 Jul; 39(7):432.e1-432.e7. PubMed ID: 33257219
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The FUTURE Trial: A Multicenter Randomised Controlled Trial on Target Biopsy Techniques Based on Magnetic Resonance Imaging in the Diagnosis of Prostate Cancer in Patients with Prior Negative Biopsies.
    Wegelin O; Exterkate L; van der Leest M; Kummer JA; Vreuls W; de Bruin PC; Bosch JLHR; Barentsz JO; Somford DM; van Melick HHE
    Eur Urol; 2019 Apr; 75(4):582-590. PubMed ID: 30522912
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Magnetic resonance imaging /ultrasonography fusion transperineal prostate biopsy for prostate cancer: Initial experience at a Middle Eastern tertiary medical centre.
    El-Achkar A; Al-Mousawy M; Abou Heidar N; Moukaddem H; Hussein H; Mouallem N; El-Hajj A; Bulbul M
    Arab J Urol; 2021; 19(4):454-459. PubMed ID: 34881061
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prostate cancer detection using magnetic resonance imaging-transrectal ultrasound fusion biopsy: A retrospective cohort study.
    Pratihar SK; Khanna A; Vasudeo V; Gupta R; Saurabh N; Kumar B; Ali M; Akotkar SS; Rawal SK; Singh A
    Indian J Urol; 2023; 39(4):297-302. PubMed ID: 38077193
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiparametric MRI-ultrasonography software fusion prostate biopsy: initial results using a stereotactic robotic-assisted transperineal prostate biopsy platform comparing systematic vs targeted biopsy.
    Lee AYM; Yang XY; Lee HJ; Law YM; Huang HH; Lau WKO; Lee LS; Ho HSS; Tay KJ; Cheng CWS; Yuen JSP; Chen K
    BJU Int; 2020 Nov; 126(5):568-576. PubMed ID: 32438463
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transperineal biopsy as a new technique versus well-established transrectal biopsy for diagnosis of prostate cancer - A comparative study.
    Eltafahny A; Alshamlan Y; Almazeedi A; Aldousari S; Salem SM
    Urol Ann; 2024; 16(2):155-159. PubMed ID: 38818431
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PIRADS≥4 MRI lesion: Is performing systematic biopsies still essential for detecting clinically significant prostate cancer?
    Taha F; Branchu B; Demichel N; Goudaimy S; Bui AP; Delchet O; Larre S
    Fr J Urol; 2024 Mar; 34(2):102572. PubMed ID: 38330830
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiparametric MRI/TRUS Fusion Prostate Biopsy: Advantages of a Transperineal Approach.
    Pepe P; Garufi A; Priolo GD; Pennisi M
    Anticancer Res; 2017 Jun; 37(6):3291-3294. PubMed ID: 28551679
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Investigating the equivalent performance of biparametric compared to multiparametric MRI in detection of clinically significant prostate cancer.
    Wang B; Gao J; Zhang Q; Zhang C; Liu G; Wei W; Huang H; Fu Y; Li D; Zhang B; Guo H
    Abdom Radiol (NY); 2020 Feb; 45(2):547-555. PubMed ID: 31907568
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Critical evaluation of magnetic resonance imaging targeted, transrectal ultrasound guided transperineal fusion biopsy for detection of prostate cancer.
    Kuru TH; Roethke MC; Seidenader J; Simpfendörfer T; Boxler S; Alammar K; Rieker P; Popeneciu VI; Roth W; Pahernik S; Schlemmer HP; Hohenfellner M; Hadaschik BA
    J Urol; 2013 Oct; 190(4):1380-6. PubMed ID: 23608676
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic outcomes from transrectal and transperineal prostate biopsies - experiences from a Swedish tertiary care Centre.
    Ugge H; Jarl S; Georgouleas P; Andersson SO; Sundqvist P; Frey J
    Scand J Urol; 2021 Dec; 55(6):434-440. PubMed ID: 34586039
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Randomized Controlled Trial To Assess and Compare the Outcomes of Two-core Prostate Biopsy Guided by Fused Magnetic Resonance and Transrectal Ultrasound Images and Traditional 12-core Systematic Biopsy.
    Baco E; Rud E; Eri LM; Moen G; Vlatkovic L; Svindland A; Eggesbø HB; Ukimura O
    Eur Urol; 2016 Jan; 69(1):149-56. PubMed ID: 25862143
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A systematic review and meta-analysis of magnetic resonance imaging and ultrasound guided fusion biopsy of prostate for cancer detection-Comparing transrectal with transperineal approaches.
    Loy LM; Lim GH; Leow JJ; Lee CH; Tan TW; Tan CH
    Urol Oncol; 2020 Aug; 38(8):650-660. PubMed ID: 32505458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.